Toshiki Terao
- Hematology top 5%
- Multiple Myeloma Research and Treatments 22
- Chronic Myeloid Leukemia Treatments 6
-
- Peptidase Inhibition and Analysis 5
-
- Chronic Lymphocytic Leukemia Research 6
-
- SARS-CoV-2 and COVID-19 Research 6
-
- Lymphoma Diagnosis and Treatment 10
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 6
-
- CNS Lymphoma Diagnosis and Treatment 5
- Co-authors
- Kosei MatsueMasami TakeuchiDaisuke MiuraKentaro NaritaYosuke MinamiKeitaro YokoyamaT OsawaRikako Tabata
- Cited by
- HematologyOncologyGenetics
- Journals
- SHILAP Revista de lepidopterología (3 papers)Blood (8 papers)Scientific Reports (2 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Toshiki Terao
54 papers receiving 365 citations
Peers
Comparison fields: 5 of 59
- Hematology 157
- Oncology 115
- Genetics 41
- Infectious Diseases 65
- Immunology 72
Countries citing papers authored by Toshiki Terao
This map shows the geographic impact of Toshiki Terao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiki Terao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiki Terao more than expected).
Fields of papers citing papers by Toshiki Terao
This network shows the impact of papers produced by Toshiki Terao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiki Terao. The network helps show where Toshiki Terao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toshiki Terao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 11 | |
| 13 | 2021 | 16 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 9 | |
| 16 | 2021 | 2 | |
| 17 | 2021 | 4 | |
| 18 | 2021 | 2 | |
| 19 | 2019 | 1 | |
| 20 | 2019 | 11 |
About Toshiki Terao
Toshiki Terao is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 60 papers that have together received 377 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (22 papers), Lymphoma Diagnosis and Treatment (10 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Hematology (157 citations), Oncology (115 citations) and Genetics (41 citations). Toshiki Terao has collaborated with scholars based in Japan and United States. Frequent co-authors include Kosei Matsue, Masami Takeuchi, Daisuke Miura, Kentaro Narita, Yosuke Minami, Keitaro Yokoyama, T Osawa, Rikako Tabata, Youichi Machida and Akihiro Kitadate. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.